Chemical inhibitors of AA408296 can effectively modulate its activity through various intracellular signaling pathways. Staurosporine is a broad-spectrum kinase inhibitor, which targets the protein kinases responsible for phosphorylating AA408296, thereby preventing its functional activation. Similarly, LY294002 and Wortmannin exert their effects by inhibiting phosphoinositide 3-kinases (PI3K), a group of enzymes involved in cellular functions such as cell growth and survival, and by extension, the activity of AA408296. U0126 and PD98059 are both selective for MEK1/2, elements of the MAPK/ERK pathway, which is known to regulate proteins like AA408296. By inhibiting MEK, these chemicals prevent the downstream activation of AA408296. SP600125 and SB203580 are selective inhibitors for the c-Jun N-terminal kinase (JNK) and p38 MAP kinase, respectively, both of which are part of stress-activated protein kinase pathways that can regulate the activity of AA408296.
Further regulation of AA408296 is achieved through the targeting of mTOR by Rapamycin. The inhibition of mTOR leads to a cascade of effects that suppress the activation of AA408296, thereby inhibiting its function within the cell. In addition, Dasatinib and PP2, both Src family kinase inhibitors, prevent the phosphorylation and subsequent activation of AA408296 by targeting the Src family kinases. Sorafenib's multi-kinase inhibition profile allows it to disrupt the function of various receptor tyrosine kinases that would otherwise contribute to the regulation of AA408296. Finally, Lapatinib provides a dual inhibition mechanism targeting both EGFR and HER2, which are receptors implicated in the regulation of AA408296. Through these diverse yet specific mechanisms, each of these chemical inhibitors can regulate the function of AA408296 by modulating the activity of kinases and receptors that are integral to its activation and function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases. It can inhibit AA408296 by inhibiting the kinases that phosphorylate AA408296, thus preventing its activation and subsequent signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a phosphoinositide 3-kinases (PI3K) inhibitor. Given that PI3K signaling can lead to the activation of several downstream proteins including AA408296, inhibition of this pathway can result in the functional inhibition of AA408296. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK), which is involved in cell signaling pathways that could activate AA408296. By inhibiting JNK, SP600125 can suppress the functional activity of AA408296. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAP kinase, which is implicated in the regulation of proteins similar to AA408296. Inhibition of p38 MAPK can lead to the functional inhibition of AA408296 by blocking its activation within this signaling pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a selective inhibitor of MEK, which potentially regulates proteins like AA408296 through the MAPK/ERK pathway. By inhibiting MEK, PD98059 can prevent the functional activation of AA408296. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits the mechanistic target of rapamycin (mTOR), a central regulator of cell growth and proliferation. As mTOR can control pathways that activate AA408296, its inhibition can suppress the functional activity of AA408296. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is an inhibitor of PI3K, which is known to regulate various proteins through signaling pathways. By inhibiting PI3K, Wortmannin can lead to the functional inhibition of AA408296. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a Src family kinase inhibitor. Src kinases can phosphorylate and activate proteins like AA408296, so inhibition of these kinases by Dasatinib can functionally inhibit AA408296. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an inhibitor of Src family tyrosine kinases. These kinases are important for the activation of certain proteins, and their inhibition by PP2 can lead to functional inhibition of AA408296. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Sorafenib targets multiple receptor tyrosine kinases involved in the regulation of cell proliferation and survival. By inhibiting these kinases, Sorafenib can functionally inhibit the activity of AA408296. | ||||||